Continuous hyperthermic peritoneal perfusion (CHPP) - Preliminary experiences

Yuan Chang Chung, Ming Te Huang, Ching Nien Chang

Research output: Contribution to journalArticle

Abstract

Continuous hyperthermic peritoneal perfusion (CHPP) with anticancer agent in warm saline was performed in 9 patients with peritoneal dissemination and local-advanced intraabdominal malignancy following resection of primary or metastatic lesions. Immediately after excision of tumor and lymphadenectomy, CHPP was performed using saline containing 16 μg/ml of mitomycin-C (MMC) and 1500 μg/ml of 5-Flurouracil (5Fu) and warm at the temperature of 42 to 43 °C for 60 minutes. Five patients are cases of colo-rectal cancer with cancerous peritonitis. Two patients are cases of local advanced rectal cancer, who received CHPP for the purpose of prevention local recurrence of malignancy. One patient is a case of pancreatic cancer with cancerous peritonitis who received twice CHPP. The last one is a case of recurrent gastric cancer with cancerous peritonitis. He is the only one patient expired after CHPP. There is no immediate postoperative complication in these cases. Only transient change of liver function, WBC count, and albumin level were noted. CHPP treatment is a safe method in eradicating cancer cells in peritoneal dissemination or local advanced condition.

Original languageEnglish
Pages (from-to)379-384
Number of pages6
JournalBiomedical Engineering - Applications, Basis and Communications
Volume6
Issue number3
Publication statusPublished - Jan 1 1994
Externally publishedYes

Fingerprint

Mitomycin
Liver
Antineoplastic Agents
Tumors
Albumins
Perfusion
Cells
Peritonitis
Rectal Neoplasms
Temperature
Neoplasms
Lymph Node Excision
Pancreatic Neoplasms
Stomach Neoplasms
Recurrence

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

Continuous hyperthermic peritoneal perfusion (CHPP) - Preliminary experiences. / Chung, Yuan Chang; Huang, Ming Te; Chang, Ching Nien.

In: Biomedical Engineering - Applications, Basis and Communications, Vol. 6, No. 3, 01.01.1994, p. 379-384.

Research output: Contribution to journalArticle

@article{55351518529f493693c4df78a65e9c97,
title = "Continuous hyperthermic peritoneal perfusion (CHPP) - Preliminary experiences",
abstract = "Continuous hyperthermic peritoneal perfusion (CHPP) with anticancer agent in warm saline was performed in 9 patients with peritoneal dissemination and local-advanced intraabdominal malignancy following resection of primary or metastatic lesions. Immediately after excision of tumor and lymphadenectomy, CHPP was performed using saline containing 16 μg/ml of mitomycin-C (MMC) and 1500 μg/ml of 5-Flurouracil (5Fu) and warm at the temperature of 42 to 43 °C for 60 minutes. Five patients are cases of colo-rectal cancer with cancerous peritonitis. Two patients are cases of local advanced rectal cancer, who received CHPP for the purpose of prevention local recurrence of malignancy. One patient is a case of pancreatic cancer with cancerous peritonitis who received twice CHPP. The last one is a case of recurrent gastric cancer with cancerous peritonitis. He is the only one patient expired after CHPP. There is no immediate postoperative complication in these cases. Only transient change of liver function, WBC count, and albumin level were noted. CHPP treatment is a safe method in eradicating cancer cells in peritoneal dissemination or local advanced condition.",
author = "Chung, {Yuan Chang} and Huang, {Ming Te} and Chang, {Ching Nien}",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "6",
pages = "379--384",
journal = "Journal of Chinese Corrosion Engineering",
issn = "1016-2372",
publisher = "World Scientific Publishing Co. Pte Ltd",
number = "3",

}

TY - JOUR

T1 - Continuous hyperthermic peritoneal perfusion (CHPP) - Preliminary experiences

AU - Chung, Yuan Chang

AU - Huang, Ming Te

AU - Chang, Ching Nien

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Continuous hyperthermic peritoneal perfusion (CHPP) with anticancer agent in warm saline was performed in 9 patients with peritoneal dissemination and local-advanced intraabdominal malignancy following resection of primary or metastatic lesions. Immediately after excision of tumor and lymphadenectomy, CHPP was performed using saline containing 16 μg/ml of mitomycin-C (MMC) and 1500 μg/ml of 5-Flurouracil (5Fu) and warm at the temperature of 42 to 43 °C for 60 minutes. Five patients are cases of colo-rectal cancer with cancerous peritonitis. Two patients are cases of local advanced rectal cancer, who received CHPP for the purpose of prevention local recurrence of malignancy. One patient is a case of pancreatic cancer with cancerous peritonitis who received twice CHPP. The last one is a case of recurrent gastric cancer with cancerous peritonitis. He is the only one patient expired after CHPP. There is no immediate postoperative complication in these cases. Only transient change of liver function, WBC count, and albumin level were noted. CHPP treatment is a safe method in eradicating cancer cells in peritoneal dissemination or local advanced condition.

AB - Continuous hyperthermic peritoneal perfusion (CHPP) with anticancer agent in warm saline was performed in 9 patients with peritoneal dissemination and local-advanced intraabdominal malignancy following resection of primary or metastatic lesions. Immediately after excision of tumor and lymphadenectomy, CHPP was performed using saline containing 16 μg/ml of mitomycin-C (MMC) and 1500 μg/ml of 5-Flurouracil (5Fu) and warm at the temperature of 42 to 43 °C for 60 minutes. Five patients are cases of colo-rectal cancer with cancerous peritonitis. Two patients are cases of local advanced rectal cancer, who received CHPP for the purpose of prevention local recurrence of malignancy. One patient is a case of pancreatic cancer with cancerous peritonitis who received twice CHPP. The last one is a case of recurrent gastric cancer with cancerous peritonitis. He is the only one patient expired after CHPP. There is no immediate postoperative complication in these cases. Only transient change of liver function, WBC count, and albumin level were noted. CHPP treatment is a safe method in eradicating cancer cells in peritoneal dissemination or local advanced condition.

UR - http://www.scopus.com/inward/record.url?scp=0028449293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028449293&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 379

EP - 384

JO - Journal of Chinese Corrosion Engineering

JF - Journal of Chinese Corrosion Engineering

SN - 1016-2372

IS - 3

ER -